Microbiosis in pathogenesis and intervention of atopic dermatitis

International Immunopharmacology

Volumn 69, Issue , 2019, Pages 263-269

  Dou, Jianhua ^a   Zeng, Jinrong ^a   Wu, Kathy ^a   Tan, Wenbin ^b   Gao, Lihua ^a   Lu, Jianyun ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; Gut microbiome; Skin microbiome; Therapeutic intervention

Indexed keywords

ANTIBIOTIC AGENT; BLEACHING AGENT; EMOLLIENT AGENT; PETROLATUM; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; STEROID;

ATOPIC DERMATITIS; DYSBIOSIS; HUMAN; INTESTINE FLORA; MICROBIOME; NONHUMAN; OZONATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN FLORA; STAPHYLOCOCCUS AUREUS; TOPICAL TREATMENT; ANIMAL; BIOLOGICAL THERAPY; IMMUNE SYSTEM; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; SKIN; SYMBIOSIS; TRENDS;

ANIMALS; BIOLOGICAL THERAPY; DERMATITIS, ATOPIC; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; SKIN; SYMBIOSIS;

EID: 85061150464     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2019.01.030     Document Type: Review

References (95)

1. Wallach, D., Taïeb, A., Atopic dermatitis/atopic eczema. Chem. Immunol. Allergy, 100, 2014, 81.
2. Illi, S., von Mutius, E., Lau, S., et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J. Allergy Clin. Immunol. 113 (2004), 925–931.
3. Garmhausen, D., Hagemann, T., Bieber, T., et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 68 (2013), 498–506.
4. Silverberg, J.I., Hanifin, J.M., Adult eczema prevalence and associations with asthma andother health and demographic factors: AUS population–based study. J. Allergy Clin. Immunol. 132 (2013), 1132–1138.
5. Ley, R.E., Peterson, D.A., Gordon, J.I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006), 837–848.
6. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biol., 14, 2016, e1002533.
7. Turnbaugh, P.J., Ley, R.E., Hamady, M., et al. The human microbiome project. Chin. J. Microecol., 52, 2012, 315.
8. Riiser, A., The human microbiome, asthma, and allergy. Allergy, Asthma Clin. Immunol., 11, 2015, 35.
9. Fyhrquist, N., Salava, A., Auvinen, P., et al. Skin Biomes. Curr Allergy Asthma Rep 16 (2016), 1–7.
10. Grice, E.A., Segre, J.A., The skin microbiome. Nat. Rev. Microbiol., 9, 2011, 244.
11. Otto, M., Staphylococcus epidermidis — the ‘accidental’ pathogen. Nat. Rev. Microbiol. 7 (2009), 555–567.
12. Fierer, N., Lauber, C.L., Zhou, N., et al. Forensic identification using skin bacterial communities. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 6477–6481.
13. Laura, M., Marta, G., Hans, H., et al. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One, 8, 2013, e66986.
14. Penders, J., Stobberingh, E.E., Pa, V.D.B., et al. The role of the intestinal microbiota in the development of atopic disorders. Allergy 62 (2010), 1223–1236.
15. Guarner, F., Malagelada, J.R., Gut flora in health and disease. Lancet 361 (2003), 512–519.
16. Williams, M.R., Gallo, R.L., The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep, 15, 2015, 65.
17. Kong, H.H., Oh, J., Deming, C., et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22 (2012), 850–859.
18. Leyden, J.J., Marples, R.R., Kligman, A.M., Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol., 90, 2010, 525.
19. Zeeuwen, P.L., Boekhorst, J., Bogaard, E.H.V.D., et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol., 13, 2012, R101.
20. Cogen, A.L., Nizet, V., Gallo, R.L., Skin microbiota: a source of disease or defence?. Br. J. Dermatol. 158 (2010), 442–455.
21. Gensollen, T., Blumberg, R.S., Correlation between early-life regulation of the immune system by microbiota and allergy development. J. Allergy Clin. Immunol., 139, 2017, 1084.
22. Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., et al. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol., 129, 2012 (434-40.e2).
23. Penders, J., Stobberingh, E.E., Thijs, C., et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin. Exp. Allergy 36 (2010), 1602–1608.
24. Lee, E., Lee, S.Y., Kang, M.J., et al. Clostridia in the gut and onset of atopic dermatitis via eosinophilic inflammation. Ann. Allergy Asthma Immunol., 117, 2016 (91-2.e1).
25. Bridgman, S.L., Kozyrskyj, A.L., Scott, J.A., et al. Gut microbiota and allergic disease in children. Ann. Allergy Asthma Immunol. 116 (2016), 99–105.
26. Kirjavainen, P.V., Arvola, T., Salminen, S.J., et al. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?. Gut, 51, 2002, 51.
27. Nylund, L., Nermes, M., Isolauri, E., et al. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 70 (2015), 241–244.
28. Knor, T., Meholjić-Fetahović A., Mehmedagić A., Stratum corneum hydration and skin surface pH in patients with atopic dermatitis. Acta Dermatovenerol. Croat., 19, 2011, 242.
29. Rippke, F., Schreiner, V., Doering, T., et al. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am. J. Clin. Dermatol., 5, 2004, 217.
30. Sinha, B., François, P.P., Nüsse, O., et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell. Microbiol. 1 (2010), 101–117.
31. Van, H.M.L., Bishop, B.M., Dean, S.N., Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol., 11, 2011, 114.
32. Harder, J., Bartels, J., Christophers, E., et al. Isolation and characterization of human β-Defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276 (2001), 5707–5713.
33. Py, O., T O, C B, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347 (2002), 1151–1160.
34. Nomura, I., Goleva, E., Howell, M.D., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171 (2003), 3262–3269.
35. Howell, M.D., Novak, N., Bieber, T., et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. Dig. World Core Med. J., 125, 2006, 738.
36. Arad, G., Levy, R., Nasie, I., et al. Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. Cytokine, 56, 2011, 29.
37. Walev, I., Martin, E., Jonas, D., et al. Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect. Immun. 61 (1993), 4972–4979.
38. Bantel, H., Sinha, B., Domschke, W., et al. α-Toxin is a mediator of Staphylococcus aureus–induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J. Cell Biol. 155 (2001), 637–648.
39. Naik, S., Bouladoux, N., Wilhelm, C., et al. Compartmentalized control of skin immunity by resident commensals. Science 337 (2012), 1115–1119.
40. Cogen, A.L., Yamasaki, K., Sanchez, K.M., et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J. Investig. Dermatol. 130 (2010), 192–200.
41. Wanke, I., Steffen, H., Christ, C., et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J. Investig. Dermatol. 131 (2011), 382–390.
42. Iwase, T., Uehara, Y., Shinji, H., et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature, 465, 2010, 346.
43. Otto, M., Staphylococcus colonization of the skin and antimicrobial peptides. Expert. Rev. Dermatol., 5, 2010, 183.
44. Xia, X., Li, Z., Liu, K., et al. Staphylococcal LTA-induced miR-143 inhibits Propionibacterium acnes-mediated inflammatory response in skin. J. Investig. Dermatol. 136 (2016), 621–630.
45. Kobayashi, T., Glatz, M., Amagai, M., et al. Dysbiosis and Staphyloccus aureus colonization drives inflammation in atopic dermatitis. Immunity 42 (2015), 756–766.
46. Nakamura, Y., Oscherwitz, J., Cease, K.B., et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature, 503, 2013, 397.
47. Jun, S.H., Lee, J.H., Kim, S.I., et al. Staphylococcus aureus-derived membrane vesicles exacerbate skin inflammation in atopic dermatitis. Clin. Exp. Allergy, 47, 2016.
48. Lebeer, S., Vanderleyden, J., De Keersmaecker, S.C., Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8 (2010), 171–184.
49. Smits, H.H., Engering, A., Van, dKD, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115 (2005), 1260–1267.
50. Nowrouzian, F.L., Lina, G., Hodille, E., et al. Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema. Br. J. Dermatol., 176, 2016, 439.
51. Reichardt, N., Duncan, S.H., Young, P., et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8 (2014), 1323–1335.
52. Song, H., Yoo, Y., Hwang, J., et al. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J. Allergy Clin. Immunol. 137 (2016), 852–860.
53. Thorburn, Alison, et al. Diet, metabolites, and “Western-lifestyle” inflammatory diseases. Immunity 40 (2014), 833–842.
54. Smith, P.M., Howitt, M.R., Panikov, N., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
55. Kaikiri, H., Miyamoto, J., Kawakami, T., et al. Supplemental feeding of a gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, alleviates spontaneous atopic dermatitis and modulates intestinal microbiota in NC/nga mice. Int. J. Food Sci. Nutr. 68 (2017), 1–11.
56. Matsumoto, M., Ebata, T., Hirooka, J., et al. Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Ann. Allergy Asthma Immunol. 113 (2014), 209–216.
57. Jin, U.H., Lee, S.O., Sridharan, G., et al. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol. Pharmacol., 85, 2014, 777.
58. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13 (2012), 701–712.
59. Yokoyama, S., Hiramoto, K., Koyama, M., et al. Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model. Exp. Dermatol. 24 (2015), 779–784.
60. Akiyama, T., Carstens, M.I., Carstens, E., Transmitters and pathways mediating inhibition of spinal itch-signaling neurons by scratching and other counterstimuli. PLoS One, 6, 2011, e22665.
61. Lee, H.J., Park, M.K., Kim, S.Y., et al. Serotonin induces melanogenesis via serotonin receptor 2A. Br. J. Dermatol. 165 (2011), 1344–1348.
62. O'Neill, C.A., Monteleone, G., Mclaughlin, J.T., et al. The gut-skin axis in health and disease: a paradigm with therapeutic implications. BioEssays 38 (2016), 1167–1176.
63. Widmer, G., Ferrer, L., Favrot, C., et al. Glucocorticosteroids and ciclosporin do not significantly impact canine cutaneous microbiota. BMC Vet. Res., 14, 2018, 51.
64. Gonzalez, M.E., Schaffer, J.V., Orlow, S.J., et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J. Am. Acad. Dermatol., 75, 2016 (481-93.e8).
65. Brunner, P.M., Khattri, S., Garcet, S., et al. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis. J. Allergy Clin. Immunol. 138 (2016), 169–178.
66. Ewing, C.I., Ashcroft, C., Gibbs, A.C., et al. Flucloxacillin in the treatment of atopic dermatitis. Br. J. Dermatol. 138 (1998), 1022–1029.
67. Lever, R., Hadley, K., Downey, D., et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br. J. Dermatol. 119 (2010), 189–198.
68. Gilani, S.J., Gonzalez, M.I., Finlay, A.Y., et al. Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin. Dig. World Core Med. J. 30 (2010), 10–13.
69. NA F, MJ R, E T-J, et al. Oral and topical antibiotics for clinically infected eczema in children: a pragmatic randomized controlled trial in ambulatory care. Ann. Fam. Med. 15 (2017), 124–130.
70. Gong, J.Q., Lin, L., Lin, T., et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br. J. Dermatol. 155 (2006), 680–687.
71. Greene, A.K., Few, B.K., Serafini, J.C., A comparison of ozonation and chlorination for the disinfection of stainless steel surfaces. J. Dairy Sci., 76, 1993, 3617.
72. Stalder, K., Klosterkötter, W., Studies on the reappearing of a bacterial flora in drinking water after ozonization (author's transl)., 161, 1976, 474.
73. Bassi, P., Sbrascini, S., Mattassi, R., et al. Ozone in the treatment of herpes zoster., 28, 1982, 328.
74. Moureu, S., Violleau, F., Ali, H.-L.D., et al. Ozonation of sunflower oils: impact of experimental conditions on the composition and the antibacterial activity of ozonized oils. Chem. Phys. Lipids 186 (2015), 79–85.
75. Lu, J., Li, M., Huang, J., et al. Effect of ozone on Staphylococcus aureus colonization in patients with atopic dermatitis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 43 (2018), 157–162.
76. Lu, J., Li, M., Gao, L., et al. Attenuation rules and germicidal efficacy of ozoneted water. Zhong Nan Da Xue Xue Bao Yi Xue Ban 43 (2018), 143–146.
77. Song, M., Zeng, Q., Xiang, Y., et al. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol. Med. Rep. 17 (2018), 2449–2455.
78. Lu, J., Chen, M., Gao, L., et al. A preliminary study on topical ozonated oil in the therapeutic management of atopic dermatitis in murine. J. Dermatol. Treat., 2018, 1–21.
79. Clark, A.R., Weber, T.M., Miller, D.W., et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. Retour Au Numéro 10 (2011), 531–537.
80. Pennick, G., Harrison, S., Jones, D., et al. Superior effect of isostearyl isostearate on improvement in stratum corneum water permeability barrier function as examined by the plastic occlusion stress test. Int. J. Cosmet. Sci. 32 (2010), 304–312.
81. Seite, S., Flores, G.E., Henley, J.B., et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J. Drugs Dermatol. 13 (2014), 1365–1372.
82. Czarnowicki, T., Malajian, D., Khattri, S., et al. Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer. J. Allergy Clin. Immunol., 137, 2016 (1091-102.e7).
83. Horimukai, K., Morita, K., Narita, M., et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J. Allergy Clin. Immunol., 134, 2014 (824-30.e6).
84. Lynde, C.W., Andriessen, A., Bertucci, V., et al. The skin microbiome in atopic dermatitis and its relationship to emollients. J. Cutan. Med. Surg., 20, 2016.
85. Maarouf, M., Shi, V.Y., Bleach for atopic dermatitis: beyond antimicrobials. Dermatitis, 29, 2018, 1.
86. Wong, S.M., Ng, T.G., Baba, R., Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia. J. Dermatol. 40 (2013), 874–880.
87. Yang, H.J., Min, T.K., Lee, H.W., et al. Efficacy of probiotic therapy on atopic dermatitis in children: a randomized, double-blind, placebo-controlled trial. Allergy, Asthma Immunol. Res. 6 (2014), 208–215.
88. Rosenfeldt, V., Benfeldt, E., Nielsen, S.D., et al. Effect of probiotic lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111 (2003), 389–395.
89. Kalliomaki, M., Probiotics in primary prevention of atopic disease. Ambul. Child Health 7 (2001), 1076–1079.
90. Chang, Y.S., Trivedi, M.K., Jha, A., et al. Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials. JAMA Pediatr., 170, 2016, 236.
91. Kim, S.O., Ah, Y.M., Yu, Y.M., et al. Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann. Allergy Asthma Immunol. 113 (2014), 217–226.
92. Boyle, R.J., Bath, F.J., Probiotics for treating eczema. Cochrane Database Syst. Rev., 4, 2008, CD006135.
93. Grüber, C., Van, S.M., Mosca, F., et al. Immunoactive prebiotics transiently prevent occurrence of early atopic dermatitis among low-atopy-risk infants. J. Allergy Clin. Immunol., 136, 2015 (1696-8.e1).
94. Silva, S.H., Guedes, A.C., Gontijo, B., et al. Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 20 (2006), 1114–1120.
95. Dotterud, L., Wilsgaard, T., Lh, Falk E., The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Int. J. Circumpolar Health 67 (2008), 254–260.